<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5236E000-C1B4-4A15-AA74-AC0A4512AA03"><gtr:id>5236E000-C1B4-4A15-AA74-AC0A4512AA03</gtr:id><gtr:name>Oxford Optronix Ltd</gtr:name><gtr:address><gtr:line1>19 - 21 Central 127</gtr:line1><gtr:line2>Milton Park</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxon</gtr:line5><gtr:postCode>OX14 4SA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Cell and Developmental Biology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5236E000-C1B4-4A15-AA74-AC0A4512AA03"><gtr:id>5236E000-C1B4-4A15-AA74-AC0A4512AA03</gtr:id><gtr:name>Oxford Optronix Ltd</gtr:name><gtr:address><gtr:line1>19 - 21 Central 127</gtr:line1><gtr:line2>Milton Park</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxon</gtr:line5><gtr:postCode>OX14 4SA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AFC8C6A6-E4CD-49C8-A64F-781774A44E7D"><gtr:id>AFC8C6A6-E4CD-49C8-A64F-781774A44E7D</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Glynne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B5134BC5-3DBF-4F2F-A186-07CB6E40673F"><gtr:id>B5134BC5-3DBF-4F2F-A186-07CB6E40673F</gtr:id><gtr:firstName>Derek</gtr:firstName><gtr:surname>Gilroy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9FE0CAAE-07A3-4E5B-B95D-C5B1BC365644"><gtr:id>9FE0CAAE-07A3-4E5B-B95D-C5B1BC365644</gtr:id><gtr:firstName>Lucie</gtr:firstName><gtr:otherNames>Hutton</gtr:otherNames><gtr:surname>Clapp</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/04BB1D5E-9A10-4073-A8DC-E06690B7920B"><gtr:id>04BB1D5E-9A10-4073-A8DC-E06690B7920B</gtr:id><gtr:firstName>Mervyn</gtr:firstName><gtr:surname>Singer</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AA91E076-F668-4496-9F12-1F6D83DE9262"><gtr:id>AA91E076-F668-4496-9F12-1F6D83DE9262</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Duchen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FBB1CF75-D3E8-4FA1-A33C-E88D117C942F"><gtr:id>FBB1CF75-D3E8-4FA1-A33C-E88D117C942F</gtr:id><gtr:firstName>Geoffrey</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Bellingan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/88AE6FB7-51B3-44B0-B39B-6193FF34C1E3"><gtr:id>88AE6FB7-51B3-44B0-B39B-6193FF34C1E3</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Vallance</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500712"><gtr:id>1E0A8CAD-15B6-441B-B285-1608F477F4D0</gtr:id><gtr:title>UCL Sepsis Group</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500712</gtr:grantReference><gtr:abstractText>UCL have a Media Office that is very proactive in alerting the media to interesting discoveries and ideas. For example, they communiqued a recent UCL Lecture given by Professor Singer which attracted intense TV, radio and press coverage both nationally and internationally, ranging from China to South Africa to North America. Many of the applicants are experienced in communicating to the lay public through television and radio programmes, e.g. the 9 o?clock News, Newsround, Medicine Now and Woman?s Hour, and being interviewed for various newspaper articles.</gtr:abstractText><gtr:technicalSummary>Sepsis is the leading cause of mortality in the critically ill. Better understanding of the underlying mechanisms will improve treatment and outcomes. With MRC funding, we formed a Sepsis Co-operative Group at UCL in 2000 with a core laboratory facility as a ?value-added? focus to support the significant amount of expertise available in this institution in models of sepsis and inflammation, in vascular, cell and mitochondrial biology, in genetics, transgenic technology, imaging and clinical research. This core laboratory has greatly facilitated sepsis research by the provision on one site of highly experienced technicians with the skills to maintain, prepare and run sophisticated and representative short- and long-term in vivo models of sepsis, and through the capability to provide tissues, isolated cells and primary cultures from numerous organs for ex vivo and in vitro studies. These investigations complement concurrent clinical studies where a number of important translational steps have already borne fruit in patient management. Conscious of the need for reduction, refinement and replacement of laboratory animals, experiments are organised to support concurrent yet separate lines of study, and to enable comparison of results obtained from in vivo, ex vivo and cell line models. Crucially, a strong management structure has harnessed the expertise held by individual researchers. This provides broad support to all cooperating groups, including cross-fertilisation of ideas through regular meetings. Assistance, collaboration and education have also been provided to other groups, both nationally and internationally. We thus request continuation of support for this facility through the funding of a Collaborative Group.</gtr:technicalSummary><gtr:fund><gtr:end>2008-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>343696</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Optronix Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tissue oxygen monitoring in shock states</gtr:description><gtr:id>963E3787-044A-4235-88A3-C5F5CDD67598</gtr:id><gtr:impact>Recently (Oct 2010) gained &amp;pound;1.2M funding from NIHR-Wellcome Trust to develop this technology for patient use</gtr:impact><gtr:outcomeId>51CE6470911-1</gtr:outcomeId><gtr:partnerContribution>They have supplied probes free of charge that allow us to more precisely monitor the animal models of shock we have developed and to assess the effects of treatments. In collaboration with UCL Business, we gained pilot study funding to support a bid to develop this technology for patient monitoring</gtr:partnerContribution><gtr:piContribution>We have used the probes to assess tissue oxygenation in various organ beds in different shock states. This novel work has been published in two papers to date, with one more shortly to be submitted for publication.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>7000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESICM, Intelligent Monitoring Award</gtr:description><gtr:end>2008-10-02</gtr:end><gtr:fundingOrg>European Society of Intensive Care Medicine (ESICM)</gtr:fundingOrg><gtr:id>A1AC19BB-E847-465E-8EC5-DFA684261F90</gtr:id><gtr:outcomeId>9AE2B66C5EE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESICM, Basic Science Award</gtr:description><gtr:end>2008-11-02</gtr:end><gtr:fundingOrg>European Society of Intensive Care Medicine (ESICM)</gtr:fundingOrg><gtr:id>2B0AB3D7-1781-4716-9F7C-772D58D1F623</gtr:id><gtr:outcomeId>5882CB6A3B90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>192000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F27C5D27-780E-44D3-B319-D9EB0EDFA85F</gtr:id><gtr:outcomeId>FF55C2EB3370</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4024310</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust SDDI</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>5944B77C-2232-44DD-9A42-11E03D3A251D</gtr:id><gtr:outcomeId>812078A28D00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>C29DAF58-8260-4033-9678-D43BD837E751</gtr:id><gtr:outcomeId>4E4313EC86B0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK Intensive Care Society Investigator Award</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Intensive Care Society</gtr:fundingOrg><gtr:id>32DBBA83-1371-4B74-8809-0676498CD646</gtr:id><gtr:outcomeId>19FA81842C70</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Development and validation of a large surface area-sensing oxygen probe that can be readily and safely inserted into tissue beds to monitor changes in tissue oxygenation during shock states, and treatment thereof.</gtr:description><gtr:id>EF9BEA34-18D7-4B66-8CC6-FF6C26D44D1A</gtr:id><gtr:impact>Attempting to develop probes for trialling in patients - recently gained &amp;pound;1.2M funding</gtr:impact><gtr:outcomeId>59DE7E5CA33</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Tissue oxygen monitoring</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1809E8AE-1FA5-469E-B6BA-7FD2073C59D1</gtr:id><gtr:title>Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ec98d99c49bc211bffdf1db4829dff7"><gtr:id>8ec98d99c49bc211bffdf1db4829dff7</gtr:id><gtr:otherNames>Barrett LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>EE1AF78FD79</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ABE08D2-474A-4B20-967B-5FD0084FF558</gtr:id><gtr:title>TREM-1 promotes survival during septic shock in mice.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f050f00a3cd1b5e6f7de6c09283271a"><gtr:id>8f050f00a3cd1b5e6f7de6c09283271a</gtr:id><gtr:otherNames>Gibot S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>D837872B30C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D523443-4E5F-4DFB-9BF0-9446588E1681</gtr:id><gtr:title>Is MOF an outcome parameter or a transient, adaptive state in critical illness?</gtr:title><gtr:parentPublicationTitle>Current opinion in critical care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c74434b31229e186742a9e213b9c88c"><gtr:id>9c74434b31229e186742a9e213b9c88c</gtr:id><gtr:otherNames>Mongardon N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1070-5295</gtr:issn><gtr:outcomeId>756BA0D5D73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B13F762D-D792-48B5-8041-21BC053371D0</gtr:id><gtr:title>Tissue oxygen monitoring in rodent models of shock.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Heart and circulatory physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756801284f692aea56448b3d02451f18"><gtr:id>756801284f692aea56448b3d02451f18</gtr:id><gtr:otherNames>Dyson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0363-6135</gtr:issn><gtr:outcomeId>71790EAE86F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7924A267-4884-465E-81C7-17CB46354267</gtr:id><gtr:title>Vasopressin: mechanisms of action on the vasculature in health and in septic shock.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ec98d99c49bc211bffdf1db4829dff7"><gtr:id>8ec98d99c49bc211bffdf1db4829dff7</gtr:id><gtr:otherNames>Barrett LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>7C15CE13530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>150F60D3-79FB-4621-A573-B2C7BC20364D</gtr:id><gtr:title>Strategies to modulate cellular energetic metabolism during sepsis.</gtr:title><gtr:parentPublicationTitle>Novartis Foundation symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee6ef1d4bc160eff411934e50f36cdf7"><gtr:id>ee6ef1d4bc160eff411934e50f36cdf7</gtr:id><gtr:otherNames>Protti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1528-2511</gtr:issn><gtr:outcomeId>F02EC27CFC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A537333-C7F2-4F59-92B2-CA7A28CB16F6</gtr:id><gtr:title>Disruption of methylarginine metabolism impairs vascular homeostasis.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d45826f73744a72402c74eea3d5f50e6"><gtr:id>d45826f73744a72402c74eea3d5f50e6</gtr:id><gtr:otherNames>Leiper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>3CCD0554B58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6D79B7-1F7D-4988-B543-7F3323064FB0</gtr:id><gtr:title>Succinate recovers mitochondrial oxygen consumption in septic rat skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee6ef1d4bc160eff411934e50f36cdf7"><gtr:id>ee6ef1d4bc160eff411934e50f36cdf7</gtr:id><gtr:otherNames>Protti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>C1E97FFA97A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EC3E0D3-A6A9-4625-8352-7F183688F809</gtr:id><gtr:title>Mechanisms of sepsis-induced cardiac dysfunction.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccc5c7335c5c21816de0a64d272cad30"><gtr:id>ccc5c7335c5c21816de0a64d272cad30</gtr:id><gtr:otherNames>Rudiger A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>190E7BA4004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF74A639-48C8-499C-8EF3-BC3F9DA62E3D</gtr:id><gtr:title>System interactions.</gtr:title><gtr:parentPublicationTitle>Novartis Foundation symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0678f249aec25ed137cd2e8aaa63b718"><gtr:id>0678f249aec25ed137cd2e8aaa63b718</gtr:id><gtr:otherNames>Singer M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1528-2511</gtr:issn><gtr:outcomeId>AC1043D2D1A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24DE9FBE-A1FF-4649-AA65-45888537FA9A</gtr:id><gtr:title>Oxidative stress and critical illness.</gtr:title><gtr:parentPublicationTitle>Minerva anestesiologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee6ef1d4bc160eff411934e50f36cdf7"><gtr:id>ee6ef1d4bc160eff411934e50f36cdf7</gtr:id><gtr:otherNames>Protti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0375-9393</gtr:issn><gtr:outcomeId>D11FCA113BC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF390619-13FF-475A-9050-1B0A08117090</gtr:id><gtr:title>Mitochondrial function in sepsis: acute phase versus multiple organ failure.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0678f249aec25ed137cd2e8aaa63b718"><gtr:id>0678f249aec25ed137cd2e8aaa63b718</gtr:id><gtr:otherNames>Singer M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>9EF7A74C261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C820B362-F528-4755-9D49-A140ABE45D37</gtr:id><gtr:title>Mechanisms of sepsis-induced organ dysfunction.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/663eaffa6127612ca496238b4cb15af9"><gtr:id>663eaffa6127612ca496238b4cb15af9</gtr:id><gtr:otherNames>Abraham E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>BF582E151D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0836FE83-9923-4B34-8DA2-4ABF1F81B3A0</gtr:id><gtr:title>BK large conductance Ca&amp;sup2;+-activated K+ channel-deficient mice are not resistant to hypotension and display reduced survival benefit following polymicrobial sepsis.</gtr:title><gtr:parentPublicationTitle>Shock (Augusta, Ga.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf1e7cbaeef1075bd17699372c071953"><gtr:id>bf1e7cbaeef1075bd17699372c071953</gtr:id><gtr:otherNames>O'Brien AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-2322</gtr:issn><gtr:outcomeId>pm_16336_26_21330953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23D99A94-C863-444E-9985-A20ACAC970F3</gtr:id><gtr:title>Early functional and transcriptomic changes in the myocardium predict outcome in a long-term rat model of sepsis.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccc5c7335c5c21816de0a64d272cad30"><gtr:id>ccc5c7335c5c21816de0a64d272cad30</gtr:id><gtr:otherNames>Rudiger A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>pm_16336_26_22988837</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500712</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>